The nightly ledger

Stock catalysts from the latest SEC filings

Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.

By event type: Acquisitions · Major contracts

Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839

Material

Wednesday 4 Nov210 filings read · 210 material

  • 8-KFiled 4 Nov 2026All industries

    Chord Energy CorpCHRD

    8-K · Item 2.02 — Results of operations

    Chord Energy reported Q3 2026 results beating guidance on volumes and cash flow. Company raised FY26 oil volume guidance ~1% to 162.5 MBopd and increased Adjusted Free Cash Flow expectations by ~$200MM. Announced $550MM Marcellus divestiture and $225MM annual run-rate cost savings.

    Gap Low · 6 → Medium · 13

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    PROCEPT BioRobotics CorpPRCT

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $98.3M (+18% YoY) with 22% U.S. procedure growth and 66% gross margin. Company reaffirms full-year 2026 guidance of $390-410M revenue. Net loss widened to $26.5M; adjusted EBITDA loss of $9.8M.

    Gap Low · 0 → Medium · 12

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Deluxe CorpDLX

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 9.1% on comparable basis; adjusted EBITDA increased 9.6% to $127.1M with margin expansion. Company raised full-year revenue and adjusted EBITDA guidance. Celero acquisition integration progressing on synergy targets.

    Recognition: Watch 34 → Watch 41Value: Strong 70 → Balanced 55

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Mgic Investment CorpMTG

    8-K · Item 2.02 — Results of operations

    Value: Balanced 61 → Strong 67

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    uniQure N.V.QURE

    8-K · Item 2.02 — Results of operations

    FDA granted priority review of BLA for AMT-130 (Huntington's disease) with May 1, 2027 PDUFA date. Company aligned with FDA on confirmatory study design; U.S. patient screening begins end-2026. Cash position of $768.4M funds operations into 2030. Pipeline programs advancing.

    Recognition: Balanced 45 → Watch 40Gap High · 34 → Very high · 57

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Software / SaaS

    Exzeo Group, Inc.XZO

    8-K · Item 2.02 — Results of operations

    Exzeo reported Q3 2026 net income of $22.3M (+5.6% YoY) and managed premium growth to $1.4B (+16.7% YoY). Adjusted revenue grew to $53.9M; however, adjusted EBITDA margin compressed to 51% from 55% due to strategic workforce and infrastructure investments.

    Gap Medium · 11 → Medium · 23

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Matson, Inc.MATX

    8-K · Item 2.02 — Results of operations

    Matson reported Q3 2026 EPS of $6.96 vs. $4.24 YoY, net income of $209.4M vs. $134.7M, and consolidated operating income of $255.2M vs. $161.0M. Company raised full-year outlook, expecting Q4 2026 consolidated operating income ~50% higher than Q4 2025.

    Gap Low · 7 → Medium · 14

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Cognex CorpCGNX

    8-K · Items 2.02, 8.01 — Results of operations

    Cognex reported record Q3 2026 revenue of $313M (+13% YoY, +19% ex-CP), operating margin 32.2%, Adjusted EPS $0.53 (+61% YoY), and raised full-year guidance. Announced RealSense acquisition and 6% dividend increase.

    Recognition: Balanced 61 → Balanced 57Gap Low · 0 → Low · 7

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Semiconductors

    SITIME CorpSITM

    8-K · Item 2.02 — Results of operations

    SiTime reported Q3 2026 revenue of $298.7M, up 257% YoY, with core CED revenue growing 202% YoY. Company achieved annualized revenue run rate above $1B post-TPD acquisition. Non-GAAP net income $130.3M ($4.01 per diluted share).

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Cadre Holdings, Inc.CDRE

    8-K · Item 2.02 — Results of operations

    Q3 2026: Net sales +30% YoY to $202.9M, net income +46% to $16.0M, adjusted EBITDA margin expanded 110bps to 20.2%. Full-year guidance raised for second consecutive quarter. $100M share repurchase authorized.

    Gap Medium · 11 → High · 25

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Rayonier IncRYN

    8-K · Item 2.02 — Results of operations

    Q3 2026: Net income $123.3M ($0.41/share); pro forma $40.0M ($0.13/share). Adjusted EBITDA $144.6M. Completed $291M timberland transactions with RMS. Repurchased $59.8M shares; approved new $300M repurchase program.

    Value: Watch 39 → Watch 34Gap Medium · 14 → Medium · 18

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Veeco Instruments IncVECO

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $209.4M (+26% YoY) exceeded expectations. GAAP net income $13.6M (+28% YoY); Non-GAAP $24.1M. FY2026 guidance raised to $790–$820M revenue. CEO cites AI infrastructure acceleration and strong order activity.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Vishay Intertechnology IncVSH

    8-K · Item 2.02 — Results of operations

    Vishay reported Q3 2026 revenue of $978.9M (highest ever, +24% YoY), gross margin of 25.5% (+600 bps), operating margin of 9.4%, and diluted EPS of $0.37. Book-to-bill of 1.29 indicates strong demand. Q4 guidance: $990M ±$15M revenue, 26.0% ±50 bps margin.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Ormat Technologies, Inc.ORA

    8-K · Item 2.02 — Results of operations

    Q3 2026: Revenue +10.2% YoY to $275.1M, net income +32.2% to $31.9M, adjusted EBITDA +11.1% to $153.8M. Energy Storage segment surged 145.2% YoY. Company raised FY2026 revenue and adjusted EBITDA guidance midpoints. EGS pipeline expanded to 5–6 GW potential.

    Gap Low · 0 → Medium · 12

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Pursuit Attractions & Hospitality, Inc.PRSU

    8-K · Item 2.02 — Results of operations

    Pursuit reported record Q3 2026 revenue of $251.5M (+4.4% YoY) and Adjusted EBITDA of $125.5M (+7% YoY). Company reaffirmed full-year Adjusted EBITDA guidance midpoint of $133M (14% growth) while narrowing range. Strong same-store metrics and balance sheet improvements support outlook.

    Recognition: Balanced 63 → Balanced 58Gap Low · 8 → Medium · 18

    Market attention has faded.

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026Semiconductors

    Power Integrations IncPOWI

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 5% sequentially to $125.5M and 6% YoY. GAAP EPS $0.32, non-GAAP EPS $0.46 (up from $0.37 prior quarter). Operating cash flow $42.6M. Dividend increased to $0.22/share for 2027.

    Value: Balanced 47 → Balanced 51Gap Low · 0 → Low · 6

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Scotts Miracle-Gro CoSMG

    8-K · Item 2.02 — Results of operations

    SMG reported FY2026 net sales of $3.29B (+1% YoY), with GAAP gross margin expanding 100bps to 32.3%. Non-GAAP adjusted EPS of $4.48 exceeded guidance. FY2027 guidance calls for 2-4% sales growth and adjusted EPS of $4.70-$4.90, with continued margin expansion and leverage improvement toward 3.0-3.5x by FY2029.

    Gap Low · 8 → Medium · 13

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Innoviva, Inc.INVA

    8-K · Item 2.02 — Results of operations

    Innoviva reported Q3 2026 results with IST U.S. net product sales up 45% YoY to $43.3M, on track for $150M+ 2026 guidance. NUZOLVENCE now commercially available. Operating income up 21.9% to $42.2M. Royalty revenue stable at $58.1M.

    Gap Low · 4 → Medium · 14

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Solstice Advanced Materials Inc.SOLS

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales of $1,046M exceeded guidance (+8% YoY). Net income $80M vs. prior-year loss. Adjusted EBITDA $265M (+13% YoY), margin 25.3% (+109 bps). Full-year guidance raised for second consecutive quarter. Strong segment growth in Electronic Materials (+31%) and Healthcare Packaging (+24%).

    Gap Very high · 72 → Very high · 77

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Marinemax IncHZO

    8-K · Item 2.02 — Results of operations

    MarineMax reported FY2026 net loss of $8.2M despite gross margin expansion to 34.9%. Q4 revenue declined 5.7% YoY; same-store sales fell 5.5% annually. Company pending $1.5B acquisition by Safe Harbor at $53/share.

    Gap Medium · 11 → Low · 6

    The gap narrowed as the filings read less positively.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Mge Energy IncMGEE

    8-K · Item 2.02 — Results of operations

    MGE Energy reported Q3 2026 earnings of $1.48 per diluted share, up 21% YoY from $1.22. Net income grew to $56.4M from $44.5M. Electric segment earnings increased $11.6M driven by renewable energy projects and AFUDC equity gains. Nine-month net income rose 23% to $138.2M.

    Recognition: Balanced 48 → Balanced 54

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Energy Recovery, Inc.ERII

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue collapsed 65% YoY to $11.2M from $32.0M; gross margin fell 2,670 bps to 37.5%; operating loss of $9.8M vs. $3.7M profit prior year. Decline attributed to war in Iran impacting megaproject channel (down 95% YoY).

    Recognition: Balanced 46 → Balanced 50Value: Balanced 61 → Watch 34

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Semiconductors

    Wolfspeed, Inc.WOLF

    8-K · Item 2.02 — Results of operations

    Wolfspeed reported Q1 FY2027 revenue of $155M (above guidance midpoint) but posted GAAP gross margin of -22%, net loss of $144M, and negative operating cash flow of $84M. Despite new supply agreements and a conditional $1.5B government loan, the company remains deeply unprofitable.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Onterris, Inc.ONT

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show net income up to $9.0M ($0.24 EPS) vs. $8.4M ($0.21 EPS) YoY. Adjusted EBITDA reached record $35.9M (17.7% margin). Operating cash flow surged 46% to $40.9M. Company reiterates FY2026 guidance, completed three accretive acquisitions, and continues board-led strategic review.

    Recognition: Watch 28 → Watch 34

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Universal Corp /Va/UVV

    8-K · Item 2.02 — Results of operations

    Value: Strong 68 → Watch 36

    The shares became dearer on AIR's value read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Coty Inc.COTY

    8-K · Item 2.02 — Results of operations

    Coty reported Q1 FY2027 results ahead of guidance with adjusted EPS of $0.16 vs. $0.12 YoY. Top 6 Prestige brands returned to 5% growth. Extended Marc Jacobs license for 40 years. Free cash flow improved to $85M. LFL sales decline narrowed to 2%.

    Recognition: Balanced 55 → Balanced 61Value: Balanced 49 → Balanced 45Gap Medium · 12 → Medium · 19

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Genworth Financial IncGNW

    8-K · Item 2.02 — Results of operations

    Value: Balanced 63 → Strong 69

    The shares became cheaper on AIR's value read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    CoreCivic, Inc.CXW

    8-K · Items 2.02, 8.01 — Results of operations

    CoreCivic reported Q3 2026 strong results: revenue up 28.2% YoY, occupancy increased to 84% from 76.7%, sold four facilities for $2.2B generating $1.8B gain, repaid $700M+ debt reducing leverage to (0.1)x, and expanded share repurchase authorization by $500M.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Aeva Technologies, Inc.AEVA

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $6.7M (86% YoY growth) exceeded prior quarter. New wins include US Air Force/Navy airborne autonomy contract, Micro-Epsilon multi-thousand sensor supply agreement, and first optical connectivity revenues. Strong liquidity of $272.5M.

    Recognition: Watch 34 → Watch 37Gap Very high · 50 → Very high · 47

    The gap narrowed — attention is catching up.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    agilon health, inc.AGL

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 6% YoY to $1.52B; net income swung to $35M profit vs. $110M loss YoY; MSER improved to 88.5% from 104.0%; company raised full-year 2026 Adjusted EBITDA guidance to $145–$155M from $75–$95M.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Staar Surgical CoSTAA

    8-K · Item 2.02 — Results of operations

    STAAR Surgical reported Q3 2026 net sales of $83.4M (down 12% YoY, but up 21% excluding prior-year deferred sales). Record 9-month revenue of $270.5M. Key positives: China sales up 31% ex-deferred; U.S. sales exceeded $6M for third consecutive quarter; EMEA up 31%; manufacturing transition to Switzerland completed; $50M share buyback authorized; presbyopia clinical trials initiating.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Vir Biotechnology, Inc.VIR

    8-K · Item 2.02 — Results of operations

    Recognition: Strong 66 → Strong 73Value: Strong 69 → Strong 73Gap Very high · 62 → Very high · 54

    The shares became cheaper on AIR's value read.

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Ardent Health, Inc.ARDT

    8-K · Item 2.02 — Results of operations

    Ardent Health reported Q3 2026 net income of $45M vs. prior-year loss of $23M, with adjusted EBITDA of $138M. Company raised full-year 2026 adjusted EBITDA guidance midpoint by 1.5% to $500–535M, citing strong operational execution, 2.9% adjusted admissions growth, and $70M+ in IMPACT cost savings.

    Recognition: Watch 42 → Balanced 58

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Option Care Health, Inc.OPCH

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show revenue growth of 4.1% to $1,493.5M, GAAP net income up 10.8%, and diluted EPS up 18.8% YoY. Company confirmed pending acquisition by Clayton, Dubilier & Rice and McKesson. Withdrew forward guidance due to pending deal.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Crane NXT, Co.CXT

    8-K · Item 2.02 — Results of operations

    CXT reported Q3 2026 sales of $497M (+12% YoY, +1% organic), GAAP EPS $0.66, Adjusted EPS $1.28. Raised full-year adjusted EPS guidance midpoint and narrowed range. Strong free cash flow of $112M. DTT segment organic sales declined.

    Gap Low · 3 → Medium · 12

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Sturm Ruger & Co IncRGR

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales grew 16.5% YoY to $147.6M; diluted EPS surged 260% to $0.36; gross margin expanded to 20.7% from 15.1%; adjusted EBITDA up 402% YoY. Company declared $0.18/share dividend and announced portfolio rationalization suspending ~$25M in low-margin products.

    Recognition: Balanced 61 → Strong 70Gap Very high · 46 → High · 42

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Avient CorpAVNT

    8-K · Item 2.02 — Results of operations

    Q3 2026 sales grew 10.5% to $891M; adjusted EPS of $0.86 beat guidance of $0.80 (+23% YoY). Company raised full-year adjusted EPS guidance to $3.22–$3.32 (14–18% growth). Strong cash generation enabled $100M YTD debt repayment and resumed share buybacks.

    Gap Low · 0 → Low · 7

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Vse CorpVSEC

    8-K · Item 2.02 — Results of operations

    VSE reported record Q3 2026 revenue of $541.0M (+91.2% YoY) and net income of $47.3M (+1,216% YoY). Adjusted EBITDA margin expanded 310 bps to 19.8%. Company raised full-year 2026 revenue and EBITDA margin guidance.

    Gap Very high · 55 → Very high · 61

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Design Therapeutics, Inc.DSGN

    8-K · Item 2.02 — Results of operations

    Design Therapeutics reported Q3 2026 results with $208.6M cash, $20.3M net loss, and R&D expenses of $16.9M. Company provided clinical milestones: DT-216P2 registrational plan update expected Q4 2026, 12-week RESTORE-FA data Q1 2027, and DT-818 Phase 1 data in 2027.

    Value: Balanced 60 → Balanced 54

    The shares became dearer on AIR's value read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Evolus, Inc.EOLS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $78.0M (+13% YoY) with fourth consecutive quarter of positive Adjusted EBITDA ($1.2M, +$4.2M YoY). Company reaffirms full-year guidance and 2028 long-term outlook while expanding pipeline through partnerships and anticipated FDA approval.

    Recognition: Balanced 59 → Balanced 55Gap High · 30 → High · 41

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Timken CoTKR

    8-K · Item 2.02 — Results of operations

    Timken reported Q3 2026 sales of $1.21B (+4.7% YoY), diluted EPS of $1.34 (+35.4%), and adjusted EPS of $1.65 (+20.4%). Company raised full-year 2026 EPS guidance to $4.05–$4.20 and adjusted EPS to $6.35–$6.50. Strong cash generation and margin expansion.

    Recognition: Balanced 64 → Balanced 59Value: Watch 28 → Watch 36Gap Low · 3 → Medium · 13

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Essential Utilities, Inc.WTRG

    8-K · Item 2.02 — Results of operations

    Essential Utilities reported Q3 2026 GAAP EPS of $0.36 and adjusted EPS of $0.38, with revenues up 6.6% YoY. Company invested $1.1B in infrastructure YTD and expects $1.7B for full year. Merger with American Water progressing toward Q1 2027 close.

    Gap Medium · 10 → Medium · 17

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Primerica, Inc.PRI

    8-K · Item 2.02 — Results of operations

    Q3 2026: Record investment sales (+19% YoY), $140B client assets (+10% YoY), $969B term life in-force. Total revenues +7%, adjusted net operating income +2%, diluted adjusted EPS +7%. Term life issued face amount declined 5%; sales force down 3%.

    Gap Low · 3 → Medium · 10

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    APA CorpAPA

    8-K · Item 2.02 — Results of operations

    Value: Balanced 50 → Balanced 59Gap Low · 0 → Low · 8

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Mfa Financial, Inc.MFA

    8-K · Item 2.02 — Results of operations

    MFA Financial reported Q3 2026 results with a GAAP net loss of $122.4M ($1.19/share) driven by Treasury yield spikes and spread widening. Distributable earnings of $0.26/share and economic book value decline of 10.6% reflect challenging mortgage market conditions.

    Gap High · 25 → Medium · 10

    The gap narrowed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Banks

    American Bitcoin Corp.ABTC

    8-K · Item 2.02 — Results of operations

    Q3 2026: ABTC grew Bitcoin holdings ~5% to ~8,427 BTC, increased Satoshis Per Share ~5% to ~11,572, achieved ~$126M net income and ~$221M Adjusted EBITDA despite seasonal power cost pressures. No share dilution via ATM or Bitcoin purchases.

    News flow: first measured — Balanced 51Gap first measured: Medium · 15

    AIR measured this for the first time; no change to report.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Myriad Genetics IncMYGN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $202.7M beat expectations with 7% sequential ARPU growth in Cancer Care Continuum. Company raised FY2026 revenue guidance mid-point and announced definitive agreement to sell Prenatal Health business to Labcorp for $210M, expected to improve profitability and growth rate.

    Recognition: Balanced 60 → Strong 65

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Tutor Perini CorpTPC

    8-K · Item 2.02 — Results of operations

    TPC reported record Q3 2026 results: $1.7B revenue (+22% YoY), $125.4M operating income (+213% YoY), $0.39 EPS (+457% YoY). Raised full-year adjusted EPS guidance to $5.90–$6.10 from $5.15–$5.45. Backlog $20.4B; strong cash generation.

    Recognition: Balanced 46 → Balanced 50Value: Balanced 54 → Balanced 51Gap High · 39 → Very high · 47

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Sezzle Inc.SEZL

    8-K · Item 2.02 — Results of operations

    Sezzle reported Q3 2026 results with 42.6% YoY revenue growth to $166.5M, 79.3% net income growth to $47.8M, and 68.1% subscriber growth to 955K. Raised FY2026 guidance four times; now expects 42.5% revenue growth and $5.45–$5.50 adjusted EPS. Introduced FY2027 preliminary guidance of $7.20 adjusted EPS.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Natural Resource Partners LpNRP

    8-K · Item 2.02 — Results of operations

    NRP reported Q3 2026 results with $44.8M free cash flow, fully repaid $13.1M credit facility balance, and declared significantly increased distribution of $2.34/unit (vs. $0.75 prior quarter). Company nearing deleveraging completion despite challenging commodity markets.

    Recognition: Watch 34 → Watch 37Gap Low · 0 → Medium · 14

    More of the market is starting to notice.

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Banks

    Chime Financial, Inc.CHYM

    8-K · Item 2.02 — Results of operations

    Chime reported Q3 2026 revenue of $718M (+32% YoY), achieved third consecutive quarter of GAAP profitability with $44M net income, and raised full-year 2026 guidance. Active Members grew 20% YoY to 10.9M with record 1.8M net additions over trailing 12 months.

    Recognition: Balanced 55 → Balanced 60Gap Low · 0 → Low · 5

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Blue Owl Capital CorpOBDC

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings show NAV growth to $14.32/share (+40 bps QoQ), strong credit quality with no new non-accrual additions, $891M new commitments, and 10.3% annualized return on net income. Base dividend maintained at $0.31/share.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Park Ohio Holdings CorpPKOH

    8-K · Item 2.02 — Results of operations

    Park-Ohio reported Q3 2026 record revenue of $459M (+15% YoY), gross margin expansion to 17.9%, and adjusted EPS of $1.04 (+60% YoY). Company raised FY2026 sales guidance to $1.75–$1.77B and adjusted EPS to $3.35–$3.50, citing strong demand across aerospace, AI data centers, and semiconductors.

    Gap Low · 0 → Low · 7

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Lemaitre Vascular IncLMAT

    8-K · Item 2.02 — Results of operations

    Q3 2026 sales grew 11% YoY to $68.0mm with 12% organic growth. Gross margin improved 90bps (adjusted). Company raised FY2026 guidance to +11% sales and +18% adjusted EPS. Acquired B. Braun vascular assets for $19.2mm.

    Recognition: Balanced 54 → Balanced 51Gap Low · 4 → Medium · 15

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Banks

    Riot Platforms, Inc.RIOT

    8-K · Items 1.02, 2.02 — Material agreement terminated

    Riot signed a 15-year, 910 MW triple-net powered land lease with a leading Frontier AI Lab at Corsicana for ~$28B total contract value (~$1.8B annual rent). Combined with prior contracts, Riot has now leased 1,151 MW representing ~$38B long-term revenue with expected $2B+ average annual NOI at full deployment.

    Recognition: Balanced 57 → Balanced 62Value: Watch 29 → Watch 26Gap Very high · 57 → Very high · 69

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Reservoir Media, Inc.RSVR

    8-K · Item 2.02 — Results of operations

    Q2 FY2027 revenue grew 10% YoY to $49.9M; Recorded Music surged 18%. Net income doubled to $4.6M. Company raised full-year FY2027 revenue and Adjusted EBITDA guidance. Strategic catalog acquisitions completed.

    Recognition: Watch 38 → Watch 42Gap Low · 7 → Medium · 20

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Edgewise Therapeutics, Inc.EWTX

    8-K · Item 2.02 — Results of operations

    Edgewise reported Q3 2026 results featuring a $1.348B gain from sevasemten sale to Servier, positive Phase 2 EDG-7500 HCM data, Phase 3 initiation expected by year-end 2026, and first patient dosed in Phase 2 EDG-15400 HFpEF trial. Cash position strengthened to $1.74B.

    Recognition: Balanced 64 → Strong 68

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Phibro Animal Health CorpPAHC

    8-K · Item 2.02 — Results of operations

    Q1 FY2027 net sales grew 6% to $386.8M, net income rose 11% to $29.5M, and diluted EPS increased 11% to $0.72. Company maintained full-year guidance of $1.55–$1.60B sales and $258–$268M adjusted EBITDA, citing strong Mineral Nutrition and Performance Products performance.

    Value: Balanced 64 → Strong 78Gap High · 37 → Very high · 54

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Viridian Therapeutics, Inc.\DEVRDN

    8-K · Item 2.02 — Results of operations

    Viridian reported Q3 2026 results with $24.7M Lumvoa revenue and 100+ patients on therapy, exceeding expectations. Pipeline advancing: elegrobart BLA submission Q1 2027, VRDN-292 phase 1 initiation Q4 2026. Cash position $955.2M supports path to profitability.

    Recognition: Balanced 61 → Strong 68Gap Very high · 48 → Very high · 45

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Rapport Therapeutics, Inc.RAPP

    8-K · Item 2.02 — Results of operations

    Rapport Therapeutics reported positive Phase 2 topline results for RAP-219 in bipolar mania, meeting primary and secondary endpoints with statistical significance. Lead candidate now has proof-of-concept in two indications. Company well-capitalized through end of 2029.

    Gap Very high · 73 → Very high · 77

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Geron CorpGERN

    8-K · Item 2.02 — Results of operations

    Geron reported Q3 2026 net income of $1.4M vs. prior-year loss of $18.4M. RYTELO revenue grew 5% QoQ to $60.1M; demand up 10%. Company initiated European commercial launch with Germany availability expected by year-end. Lowered 2026 operating expense guidance.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Dine Brands Global, Inc.DIN

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show modest same-restaurant sales growth (Applebee's +0.9%, IHOP +0.8%) but significant year-over-year declines in net income ($4.5M vs $7.0M), EPS ($0.37 vs $0.48), and nine-month adjusted free cash flow ($12.8M vs $68.2M). Operating cash flow declined 55% YTD.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    American Financial Group IncAFG

    8-K · Items 2.02, 8.01 — Results of operations

    AFG reported Q3 2026 record core net operating earnings of $3.97 per share (48% YoY increase), record P&C pretax operating income of $406M, 9% premium growth, and declared a $3.50 special dividend ($290M aggregate). Annualized core operating ROE of 26%.

    Gap Low · 3 → Medium · 18

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Trinity Capital Inc.TRIN

    8-K · Item 2.02 — Results of operations

    Trinity Capital reported Q3 2026 results with record NII of $49.9M (up 34.9% YoY), 15.5% ROAE, NAV of $13.61/share, and $614.1M in funded investments. Maintained 28 consecutive quarters of consistent dividends at $0.51 for Q4.

    Gap Medium · 18 → High · 31

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    ARKO Corp.ARKO

    8-K · Item 2.02 — Results of operations

    Q3 2026 net income and Adjusted EBITDA exceeded prior year; full-year 2026 guidance raised to $156–157M. Strategic USPP acquisition announced (280M gallons, ~$30M annualized EBITDA accretion). Quarterly dividend of $0.50/share declared.

    Gap Very high · 89 → Very high · 93

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Warrior Met Coal, Inc.HCC

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show 48% sales volume growth, 76% Adjusted EBITDA increase to $124M, net income of $49.3M, and $166M operating cash flow. Company declared $2.00/share special dividend, demonstrating strong cash generation from Blue Creek mine ramp-up ahead of schedule.

    Gap Low · 8 → Medium · 18

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Personalis, Inc.PSNL

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $25.6M (77% YoY growth) driven by clinical test volume surge to 13,157 (200% increase) and Medicare coverage expansion. Clinical revenue jumped to $4.4M from $0.4M. Cash position strong at $190.6M. Pending Tempus merger limits forward guidance.

    Gap Low · 0 → Low · 5

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Nuvation Bio Inc.NUVB

    8-K · Item 2.02 — Results of operations

    Q3 2026: IBTROZI achieved $27.5M net product revenue (18% QoQ growth), established as ROS1 market leader. FDA approved sNDA with 49.7-month median duration of response. Safusidenib granted Fast Track Designation for IDH1-mutant glioma. Cash position $663.4M.

    Recognition: Balanced 52 → Balanced 48Gap High · 26 → High · 38

    Market attention has faded.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Franklin Covey CoFC

    8-K · Item 2.02 — Results of operations

    FC reported Q4 and FY2026 results within guidance. Enterprise North America invoiced amounts grew 4%, deferred revenue surged 17%, and Q4 Adjusted EBITDA increased 9%. FY2027 guidance projects revenue and EBITDA growth.

    Value: Watch 29 → Watch 33Gap Low · 0 → Medium · 16

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    HCI Group, Inc.HCI

    8-K · Item 2.02 — Results of operations

    HCI Group reported Q3 2026 pre-tax income of $116M (vs. $91M YoY) and diluted EPS of $6.45 (vs. $4.90 YoY). Nine-month pre-tax income reached $343M (vs. $285M YoY). Gross loss ratio improved to 20.7% from 22.0%. Premium growth of 5-7% driven by higher policy volume.

    Value: Watch 37 → Watch 41Gap Medium · 12 → Medium · 20

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Opko Health, Inc.OPK

    8-K · Item 2.02 — Results of operations

    OPKO agreed to sell substantially all remaining BioReference diagnostic operations to Labcorp for $722M cash plus up to $150M contingent consideration. Company also secured $125M additional royalty financing and advanced multiple clinical programs including Phase 1/2a dosing of OPK-8801001 for acromegaly.

    Value: Strong 68 → Strong 74Gap High · 25 → High · 34

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Stanley Black & Decker, Inc.SWK

    8-K · Item 2.02 — Results of operations

    SWK reported Q3 2026 results with 4% organic growth, 760 bps gross margin expansion, and raised full-year 2026 EPS guidance significantly (113% GAAP growth at midpoint). Board approved $1B share repurchase authorization.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    BillionToOne, Inc.BLLN

    8-K · Item 2.02 — Results of operations

    BillionToOne reported Q3 2026 revenue of $123.0M (+47% YoY), with prenatal up 41% and oncology up 96%. Raised full-year 2026 guidance to $460–470M (+51–54% growth). Maintained GAAP profitability while launching new product.

    Recognition: Balanced 62 → Balanced 58Gap Medium · 22 → High · 33

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Vishay Precision Group, Inc.VPG

    8-K · Item 2.02 — Results of operations

    Q3 2026 adjusted EPS of $0.14 declined 53% YoY from $0.30. Adjusted operating margin fell to 4.9% from 6.9%. Currency headwinds ($3.4M) and gross margin compression offset 9.6% revenue growth. Nine-month adjusted EPS down 55% YoY.

    Recognition: Watch 41 → Watch 35

    Market attention has faded.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Software / SaaS

    Hubspot IncHUBS

    8-K · Item 2.02 — Results of operations

    HubSpot reported Q3 2026 revenue of $947.6M (+17% YoY), beating guidance. GAAP operating income surged to $71.9M from $11.2M; non-GAAP operating income grew 33% to $214.2M. Customer count reached 311,704 (+12%). Full-year guidance raised to $3.685–$3.687B revenue (+18% YoY).

    Recognition: Strong 67 → Balanced 61

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Industrials

    MATERION CorpMTRN

    8-K · Item 2.02 — Results of operations

    Materion reported record Q3 2026 results with net sales of $567.3M (+27.6% YoY), net income of $38.3M (+50.6% YoY), and adjusted EPS of $1.93 (+36.9% YoY). Company raised full-year adjusted EPS guidance to $7.10–$7.40 (+33% midpoint YoY). Record backlog and incoming orders up ~35% and ~25% YoY.

    Recognition: Balanced 63 → Balanced 57Value: Weak 21 → Weak 24Gap Low · 2 → Medium · 13

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Adient plcADNT

    8-K · Item 2.02 — Results of operations

    Q4 FY2026 net loss of $47M vs. $18M profit prior year. Full-year net loss of $17M vs. $281M loss prior year. Restructuring charges elevated at $74M (Q4) and $108M (FY). Adjusted EBITDA flat YoY at $884M, but margins compressed in Americas segment.

    News flow: Balanced 48 → Balanced 51Value: Very strong 81 → Very strong 84Gap Low · 0 → High · 35

    The filings read more positively.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    ESAB CorpESAB

    8-K · Item 2.02 — Results of operations

    ESAB reported Q3 2026 record sales of $825M (+13.3% reported, +2.3% organic) but reduced full-year guidance. Core adjusted EBITDA forecast lowered to $603–607M from $615–625M; core adjusted EPS guidance cut to $5.28–$5.33 from $5.40–$5.50. Organic growth outlook reduced to 1.6–2.0% from 2.0–4.0%.

    Gap Very high · 76 → Very high · 71

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Relay Therapeutics, Inc.RLAY

    8-K · Item 2.02 — Results of operations

    Relay reported Q3 2026 results with $849M cash runway into 2029. ReDiscover-2 breast cancer trial enrollment tracking ~1 year ahead of benchmarks, completing mid-2027. ASH presentation of vascular anomalies data scheduled December 2026. New TIE2 inhibitor program announced. First FDA approval of Relay-discovered molecule (lirafugratinib) achieved.

    Recognition: Balanced 60 → Balanced 64Gap High · 31 → High · 34

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026All industries

    Quinstreet, IncQNST

    8-K · Item 2.02 — Results of operations

    QuinStreet reported record Q1 FY2027 results with revenue of $416.7M (+46% YoY), net income of $17.0M (+275% YoY), and adjusted EBITDA of $42.7M (+108% YoY). Company raised full-year FY2027 guidance for both revenue and adjusted EBITDA.

    Fundamentals: Watch 30 → Balanced 64Value: Balanced 64 → Strong 67Gap High · 29 → High · 35

    The reported numbers improved.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Sight Sciences, Inc.SGHT

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $24.9M (+25% YoY) exceeded expectations with record IDE revenue of $3.9M (+1,850% YoY). Company raised full-year 2026 revenue guidance to $92–93M (19–20% growth) and reduced cash burn 74% YoY to $2.4M.

    Gap Low · 0 → Low · 7

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Acadia Pharmaceuticals IncACAD

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenues of $342M (+22% YoY) exceeded expectations. DAYBUE sales surged 39% YoY to $140M; NUPLAZID grew 12% to $202M. Company raised full-year DAYBUE guidance to $505–$520M and narrowed total revenue range. Pipeline progress includes Phase 2 RADIANT data supporting Phase 3 development of remlifanserin in Alzheimer's disease psychosis.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    LandBridge Co LLCLB

    8-K · Item 2.02 — Results of operations

    LandBridge reported Q3 2026 revenue of $70.9M (+39% YoY), net income of $34.0M (+68% YoY), and Adjusted EBITDA of $63.7M (+42% YoY). Company raised full-year 2026 Adjusted EBITDA guidance to $220–$235M. Completed ~25,000-acre acquisition and PowerBridge commenced data center construction.

    Recognition: Balanced 56 → Balanced 51Gap Medium · 24 → High · 37

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Mineralys Therapeutics, Inc.MLYS

    8-K · Items 2.02, 5.02 — Results of operations

    Mineralys reports Q3 2026 results with lorundrostat NDA under FDA review (PDUFA target December 22, 2026). New trial data shows 46% of resistant hypertension patients achieved blood pressure targets. Commercial launch preparations advancing with expanded sales force and patient support program.

    Gap Very high · 83 → Very high · 90

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Diversified Energy CoDEC

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show strong operational execution with $256M Adjusted EBITDA, $153M Adjusted Free Cash Flow, and $157M YTD shareholder returns. Birch acquisition on track for Q4 closing, expected to increase EBITDA 55% and free cash flow >100% pro forma.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Banks

    Hut 8 Corp.HUT

    8-K · Item 2.02 — Results of operations

    Hut 8 reported Q3 2026 results with full commercialization of Beacon Point AI data center campus, $26.6B in expected contract value, 1,300 MW capacity under exclusivity, $1.07B credit facility, and $250M shareholder returns via buybacks.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Nuvectis Pharma, Inc.NVCT

    8-K · Item 2.02 — Results of operations

    Nuvectis achieved first global approval for ciprocopan (NXP100) in China for PNH in July 2026. Lead compound now in late-stage development with FDA discussions ongoing for U.S. market. Strong cash position of $140.7M extends runway to 2H 2029. NXP200 showed encouraging Phase 1b efficacy data.

    Gap High · 41 → Very high · 52

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Biotech

    UroGen Pharma Ltd.URGN

    8-K · Item 2.02 — Results of operations

    UroGen reported Q3 2026 revenue of $89.0M (vs. $27.5M YoY), driven by ZUSDURI's 35% QoQ growth to $68.0M. FDA accepted UGN-103 NDA with June 2027 PDUFA date. First UGN-501 patient dosed. Patent extended to July 2044.

    Recognition: Strong 66 → Balanced 56Value: Watch 33 → Balanced 46Gap Low · 2 → Medium · 13

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 4 Nov 2026All industries

    Dutch Bros Inc.BROS

    8-K · Item 2.02 — Results of operations

    Dutch Bros reported Q3 2026 revenue growth of 29.8% YoY to $549.8M, net income up 36.4% to $37.2M, and 14 consecutive quarters of positive same-shop sales. Raised 2026 guidance and announced accelerated 2027 shop opening target of 250 locations.

    Recognition: Strong 67 → Balanced 62Value: Weak 17 → Watch 26Gap Low · 4 → Medium · 13

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Software / SaaS

    Clear Secure, Inc.YOU

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 27.8% YoY to $292.9M with 28.3% operating margin. Net income margin expanded 600bps to 25.7%. Member growth accelerated to 46.7M (+30.7% YoY). FY2026 FCF guidance raised to $490M+. Board authorized $175M additional share repurchase.

    Recognition: Balanced 64 → Strong 70

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Harmony Biosciences Holdings, Inc.HRMY

    8-K · Item 2.02 — Results of operations

    Q3 2026: WAKIX net revenue $269M (12% YoY growth) with 400 net patient adds. Company reiterates full-year guidance of $1.0–$1.04B. BP-205 MAD study shows favorable safety/tolerability; Phase 1b data expected Q1 2027. Pitolisant GR NDA under FDA review (PDUFA April 2027). Leadership transition announced.

    Recognition: Balanced 48 → Watch 43Value: Strong 74 → Very strong 85Gap High · 38 → Very high · 51

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    PureCycle Technologies, Inc.PCT

    8-K · Items 2.02, 5.02 — Results of operations

    Q3 2026 revenue $2.3M (down from Q2 due to operational issues and NJ delays), but production recovered to 5.2M lbs (+14% QoQ). P&G products on shelves, railcar shipments begun, cosmetics shipments expected Q4. Fernando Musa appointed Executive Chairman to support commercial ramp. $393M total liquidity.

    Gap Very high · 65 → Very high · 79

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Grand Canyon Education, Inc.LOPE

    8-K · Item 2.02 — Results of operations

    GCE reported Q3 2026 results with 185.6% operating income growth to $51.5M, driven by 5.2% enrollment increase to 145,270 students. Net income rose 164.3% to $43.0M. Board approved $355M share repurchase increase. Full-year guidance provided.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026All industries

    Enact Holdings, Inc.ACT

    8-K · Item 2.02 — Results of operations

    Enact reported Q3 2026 net income of $159M ($1.15/share) and adjusted operating income of $164M ($1.19/share). Primary IIF grew 1% YoY to $275B. Loss ratio increased to 20% from 14% sequentially. Capital return guidance raised to ~$600M for 2026.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Joby Aviation, Inc.JOBY

    8-K · Item 2.02 — Results of operations

    Joby raised FY2026 revenue guidance 15% to $135–140M. Completed key FAA certification tests, began eIPP flights in Texas/Florida, expanded Air Force contracts to ~$37M, and announced acquisition of EBITDA-positive Resonant Sciences ($100M+ revenue). Blade achieved record 44K+ passengers Q3.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Industrials

    Miller Industries Inc /Tn/MLR

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 18.8% YoY to $212.2M; net income nearly doubled (+97.2%) to $6.1M. Company reaffirms full-year guidance, expands product line (65-ton rotator), advances $100M capacity expansion, and reports $200M+ military commitments with production starting 2027.

    Recognition: Watch 39 → Watch 34Gap Low · 4 → Medium · 20

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026All industries

    Root, Inc.ROOT

    8-K · Item 2.02 — Results of operations

    Root reported Q3 2026 revenue of $381M, net income of $14M, and adjusted EBITDA of $34M with 97.2% net combined ratio. Partnership channel grew 19% YoY. Renewed Carvana relationship through 2028, launched Hyundai pilot, expanded to Wyoming, and deployed new pricing model.

    Recognition: Watch 30 → Watch 27Gap Very high · 48 → Very high · 61

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 4 Nov 2026Biotech

    Arcutis Biotherapeutics, Inc.ARQT

    8-K · Item 2.02 — Results of operations

    Arcutis reported Q3 2026 net product revenue of $143.9M (+45% YoY, +11% QoQ), raised full-year 2026 guidance to $535–$545M, and advanced pipeline including Phase 3 atopic dermatitis trial and vitiligo Phase 2 results expected Q4 2026.

    Recognition: Strong 76 → Strong 71Gap Low · 0 → Low · 7

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 4 Nov 2026Industrials

    XPEL, Inc.XPEL

    8-K · Item 2.02 — Results of operations

    XPEL reported Q3 2026 revenue of $137.8M (+9.9% YoY) with gross margin expansion to 44.6% (+280 bps). Net income grew 26.3% to $16.3M ($0.59 EPS). Nine-month revenue up 12.5% to $398.2M with 18.3% net income growth.

    Recognition: Balanced 45 → Watch 42Value: Watch 26 → Watch 29Gap Very high · 60 → Very high · 69

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material

Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.